<DOC>
	<DOCNO>NCT01872845</DOCNO>
	<brief_summary>Current consensus paper recommend statin medication reduce Low density lipoprotein ( LDL ) cholesterol level less 100mg/dL ( optional 70mg/dL ) patient coronary artery disease . However , lack solid evidence whether specific kind statin superiority statins clinical outcome . Furthermore , recent data show several kind statin could adverse effect glucose metabolism increase risk development diabetes . Carotid Intimamedia thickness ( CIMT ) surrogate marker atherosclerosis predict long term cardiovascular outcomes general population also patient establish coronary artery disease . Consequently , evaluate efficacy high dose pravastatin CIMT , compare moderate dose rosuvastatin patient establish coronary artery disease . Additionally , assess clinical outcome pravastatin percutaneous coronary intervention well adverse outcome include insulin resistance new onset diabetes compare rosuvastatin . Our main hypothesis pravastatin 40mg would non-inferior rosuvastatin 20mg regard CIMT 1 year follow .</brief_summary>
	<brief_title>A Trial Comparing Effect Pravastatin Rosuvastatin Atherosclerosis Progression Measured Carotid Intima Media Thickness Patients With Coronary Artery Disease After Biolimus Eluting Stent ( Nobori® ) Implantation : CPR IMT</brief_title>
	<detailed_description />
	<mesh_term>Pravastatin</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Patients ≥ 20 year old Patients coronary artery disease candidate coronary revascularization DES implantation . Significant coronary de novo lesion ( stenosis &gt; 70 % quantitative angiographic analysis ) Patients eligible statin treatment ( initial LDL cholesterol &gt; 70mg/dL patient take lipidlowering agent ) Severe hepatic dysfunction ( 3 time normal reference value ) Pregnant woman woman potential childbearing Life expectancy &lt; 1 year</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Statin</keyword>
	<keyword>CIMT</keyword>
	<keyword>BES</keyword>
</DOC>